查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1530844

2030 年生物技术市场预测：按类型、产品类型、技术、应用、最终用户和地区进行的全球分析

Biotechnology Market Forecasts to 2030 - Global Analysis By Type (Bio-pharmacy, Bio-industries, Bio-services, Bio-agriculture, Bio-informatics and Other Types), Product Type, Technology, Application, End User and by Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2024 年全球生技市场规模为 16,514.8 亿美元，预计到 2030 年将达到 69,294 亿美元，预测期内复合年增长率为 27.0%。

生物技术是一个快速发展的领域，利用生物系统、有机体或其衍生物来开发和创造用于各种应用的技术和产品。结合生物学和技术的概念来解决医疗保健、农业和环境管理等行业的问题。生物技术正在帮助开发基因疗法和个人化医疗等尖端治疗方法。在农业方面，它正在帮助开发具有更高产量和抗虫性的基因改造作物。

根据世界卫生组织 (WHO) 的说法，生物技术有可能透过提供新的​​治疗方法方法来解决以前无法治疗的疾病，从而彻底改变医疗保健。

对个人化治疗的兴趣日益浓厚

医疗保健正因向个人化医疗的转变而转变，个人化医疗根据患者独特的遗传、环境和生活方式因素量身定制治疗。生物技术使针对患者特定需求的精准治疗和诊断成为可能。此外，基因组学和生物标记的进步使得标靶药物的开发成为可能，与传统治疗方法相比，副作用更少，疗效更高。

安全和道德问题

生物技术经常引发有关安全和伦理的问题，特别是在基因改造和干细胞研究等领域。对基因资料潜在滥用、基因改造的长期影响以及研究对象的人道待遇的担忧也可能引起公众的反对和监管审查。此外，研究进展和市场接受度也可能受到这些担忧的影响。

个体化医疗的发展

个人化医疗有很大的发展空间，它可以根据患者独特的遗传、环境和生活方式特征量身定制治疗方法。基因组资料的不断增加和生物资讯学的进步使生物技术公司能够开发出更准确、更有效的治疗方法。此外，标靶治疗、基因诊断和个人化癌症治疗的成长就是这一趋势的例子，为创新和市场扩张创造了新的机会。

来自替代技术的威胁

传统药物、学名药和非生物治疗方法是与生物技术市场竞争的一些替代技术和治疗方法。利用生物技术的产品可能面临其他领域创新的竞争，例如合成生物学和奈米技术。此外，让您的产品在拥挤的市场中脱颖而出并保持技术进步的领先地位可能是一项挑战。

COVID-19 的影响：

COVID-19 大流行对生物技术产业产生了重大影响，加速了治疗方法、疫苗和诊断设备的开发和传播。生技公司、政府和研究机构之间前所未有的合作，满足对解决方案的迫切需求，使得疫苗技术（包括 mRNA 疫苗）的快速发展成为可能。此外，这场大流行暴露了生物技术在解决全球突发卫生事件中的关键作用，并刺激了该领域的投资和创新。

预计生物製药领域在预测期内将是最大的。

生物製药产业占据生物技术市场的最大份额。该领域专门透过应用生物技术技术（例如基因治疗、单株抗体和重组DNA技术）来开发和生产药品。生物製药的市场主导地位是其对癌症、自体免疫疾病和遗传性疾病等疾病的治疗做出的重大贡献的结果。此外，对生技药品和个人化医疗不断增长的需求在生物技术产业的整体成长中发挥着重要作用，进一步增强了该产业的主导地位。

DNA定序领域预计在预测期内复合年增长率最高

在生物技术市场中，DNA定序领域的复合年增长率最高。寻找 DNA 分子内准确的核苷酸顺序称为 DNA定序，在基因组学、个人化医疗和基因研究等许多领域至关重要。此外，次世代定序(NGS) 等定序技术的快速进步显着降低了成本并提高了通量，导致对 DNA定序服务和产品的需求激增。

比例最高的地区：

北美地区占据生物技术市场的最大份额。这项优势背后的主要因素是强大的研发网络、广泛的医疗基础设施以及对生物技术创新的大量投资。领先的生物技术公司和研究机构主要位置美国，为基因组学、药物开发和生物製药的进步创造了有利的环境。此外，有利的政府法规、生物技术研究的高额资金以及高额医疗保健支出都有助于北美在全球生物技术市场中占据主导地位。

复合年增长率最高的地区：

在生物技术市场中，亚太地区的复合年增长率最高。这种快速增长的推动因素包括该地区不断扩大的医疗基础设施、生物技术研究投资的增加以及对改善医疗保健结果的更加重视。生物技术新兴企业的增加、鼓励创新的政府计划以及中国和印度等国家生物技术行业的快速扩张都是这一成长的关键因素。此外，亚太地区庞大的人口和慢性病盛行率也推动了对个人化医疗和先进生物技术解决方案的需求，使亚太地区成为全球生物技术市场中最大的高成长率地区。

免费客製化服务

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 技术分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球生技市场：依类型

  • 生物製药
  • 生物产业
  • 生物服务
  • 生物农业
  • 生物资讯学
  • 其他类型

第六章全球生技市场：依产品类型

  • 装置
  • 试剂
  • 软体和服务
  • 其他产品类型

第七章全球生技市场：依技术分类

  • 奈米生物技术
  • 组织工程和再生
  • DNA序列分析
  • 基于细胞的检测
  • 发酵
  • 聚合酵素链锁反应（PCR）技术
  • 层析法
  • 其他技术

第八章全球生技市场：依应用分类

  • 卫生保健
  • 食品和农业
  • 自然资源与环境
  • 工业加工
  • 其他用途

第九章全球生技市场：依最终用户分类

  • 製药和生物技术公司
  • 合约调查机构
  • 学术研究所
  • 其他最终用户

第十章全球生技市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第十一章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务拓展
  • 其他关键策略

第十二章 公司概况

  • Siemens
  • Novartis AG
  • Amgen Inc.
  • Johnson & Johnson Services, Inc.
  • Merck KGaA
  • General Electric
  • Abbott Laboratories
  • Novo Nordisk A/S
  • Pfizer, Inc.
  • Sanofi
  • F. Hoffmann-La Roche Ltd.
  • Vertex Pharmaceuticals Inc.
  • Agilent Technologies Inc
  • Olympus Corporation
  • Sysmex Corporation
  • Bristol-Myers Squibb
  • Thermo Fisher Scientific
  • AstraZeneca
  • Danaher
Product Code: SMRC26956

According to Stratistics MRC, the Global Biotechnology Market is accounted for $1651.48 billion in 2024 and is expected to reach $6929.40 billion by 2030 growing at a CAGR of 27.0% during the forecast period. Biotechnology is a quickly developing field that uses biological systems, organisms, or their derivatives to develop or create technologies and products for a range of uses. It addresses issues in industries like healthcare, agriculture, and environmental management by fusing concepts from biology and technology. Biotechnology helps to develop cutting-edge medical treatments such as gene therapies and personalized medicine. It aids in the development of genetically modified crops in agriculture, which provide higher yields and insect resistance.

According to the World Health Organization (WHO), biotechnology has the potential to revolutionize healthcare by providing new treatments and therapies that can address previously untreatable conditions.

Market Dynamics:

Driver:

Growing interest in customized treatment

Healthcare is being transformed by the move toward personalized medicine, which adjusts treatments based on a patient's unique genetic, environmental, and lifestyle factors. Precision therapies and diagnostics that are tailored to each patient's specific needs are made possible in large part by biotechnology. Moreover, the development of targeted medications, which have fewer side effects and greater efficacy than conventional therapies, is made possible by developments in genomics and biomarkers.

Restraint:

Safety and ethical issues

Biotechnology frequently raises questions about safety and ethics, especially in fields like genetic modification and stem cell research. Public opposition and regulatory scrutiny may result from concerns about the possible misuse of genetic data, the long-term effects of genetic alterations, and the humane treatment of research subjects. Additionally, research advancement and market acceptability may be impacted by these worries.

Opportunity:

Developments in customized medicine

There is significant room for growth in personalized medicine, which adjusts therapies based on a patient's unique genetic, environmental, and lifestyle characteristics. Biotechnology companies can now develop more precise and effective therapies owing to the growing availability of genomic data and advances in bioinformatics. Moreover, the growth of targeted therapies, genetic diagnostics, and personalized cancer treatments are examples of this trend, which is creating new opportunities for innovation and market expansion.

Threat:

Threats from alternative technologies

Traditional pharmaceuticals, generic medications, and non-biological treatments are some of the alternative technologies and therapies that compete with the biotechnology market. Products made using biotechnology may face competition from innovations in other fields like synthetic biology and nanotechnology. Additionally, differentiating products in a crowded market and staying ahead of technological advancements can be difficult tasks.

Covid-19 Impact:

The COVID-19 pandemic had a significant effect on the biotechnology industry, hastening the creation and uptake of treatments, vaccines, and diagnostic instruments. Rapid advancements in vaccine technology, including mRNA vaccines, were made possible by the unprecedented collaboration of biotech companies, governments, and research institutions in response to the pressing need for solutions. Furthermore, the pandemic also brought to light the vital role that biotechnology plays in resolving international health emergencies, spurring more investment and innovation in the field.

The Bio-pharmacy segment is expected to be the largest during the forecast period

The largest share of the biotechnology market is held by the biopharmacy segment. This section is dedicated to the development and production of pharmaceutical products through the application of biotechnological techniques, including gene therapy, monoclonal antibodies, and recombinant DNA technology. Biopharmacy's dominant position in the market is a result of its significant contributions to the treatment of diseases such as cancer, autoimmune disorders, and genetic conditions. Moreover, this sector's prominence is further enhanced by the growing demand for biologic drugs and personalized medicine, which plays a major role in the overall growth of the biotechnology industry.

The DNA sequencing segment is expected to have the highest CAGR during the forecast period

In the biotechnology market, the DNA sequencing segment is growing at the highest CAGR. Finding the exact nucleotide order within a DNA molecule is known as DNA sequencing, and it is essential for many fields, such as genomics, personalized medicine, and genetic research. Additionally, the demand for DNA sequencing services and products has surged as a result of the rapid advancements in sequencing technologies, such as next-generation sequencing (NGS), which have drastically reduced costs and increased throughput.

Region with largest share:

The largest share of the biotechnology market is held by the North American region. The main factors contributing to this dominance are the existence of a strong research and development network, a large healthcare infrastructure, and significant investments in biotech innovation. Leading biotechnology companies and research institutes are primarily located in the United States, creating an environment that is favorable for advances in genomics, drug development, and biopharmaceuticals. Moreover, favorable government regulations, significant funding for biotech research and high healthcare spending all contribute to North America's dominant position in the world biotechnology market.

Region with highest CAGR:

In the biotechnology market, the Asia-Pacific region is growing at the highest CAGR. The region's expanding healthcare infrastructure, growing investments in biotech research, and growing emphasis on enhancing healthcare outcomes are all contributing factors to this rapid growth. Growing biotech start-ups, government programs to encourage innovation and the rapidly expanding biotech sectors of nations like China and India are all major factors in this growth. Furthermore, the demand for personalized medicine and advanced biotech solutions is also being driven by the region's large population base and rising chronic disease prevalence, making Asia-Pacific the region with the fastest rate of growth in the global biotechnology market.

Key players in the market

Some of the key players in Biotechnology market include Siemens, Novartis AG, Amgen Inc., Johnson & Johnson Services, Inc., Merck KGaA, General Electric, Abbott Laboratories, Novo Nordisk A/S, Pfizer, Inc., Sanofi, F. Hoffmann-La Roche Ltd., Vertex Pharmaceuticals Inc., Agilent Technologies Inc, Olympus Corporation, Sysmex Corporation, Bristol-Myers Squibb, Thermo Fisher Scientific, AstraZeneca and Danaher.

Key Developments:

In July 2024, Boson Energy and Siemens AG have signed a Memorandum of Understanding (MoU) to facilitate collaboration on technology that converts non-recyclable waste into clean energy. The collaboration aims to advance sustainable, local energy security, enabling hydrogen-powered electric vehicle charging infrastructure without compromising grid stability or impacting consumer prices.

In June 2024, Novartis has entered an agreement to make a voluntary public takeover offer to acquire MorphoSys AG, a Germany-based, global biopharmaceutical company developing oncology medicines, for €2.7 billion. The acquisition, subject to customary closing conditions, further expands Novartis' oncology pipeline as well as its global footprint in hematology.

In May 2024, Merck, a leading science and technology company, has signed a definitive agreement to acquire life science company Mirus Bio for US$ 600 million. Based in Madison, Wisconsin, USA, Mirus Bio is a specialist in the development and commercialization of transfection reagents.

Types Covered:

  • Bio-pharmacy
  • Bio-industries
  • Bio-services
  • Bio-agriculture
  • Bio-informatics
  • Other Types

Product Types Covered:

  • Instruments
  • Reagents
  • Software and Service
  • Other Product Types

Technologies Covered:

  • Nanobiotechnology
  • Tissue Engineering and Regeneration
  • DNA Sequencing
  • Cell-based Assays
  • Fermentation
  • Polymerase Chain Reaction (PCR) Technology
  • Chromatography
  • Other Technologies

Applications Covered:

  • Healthcare
  • Food & Agriculture
  • Natural Resources & Environment
  • Industrial Processing
  • Other Applications

End Users Covered:

  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations
  • Academic and Research Institutes
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Biotechnology Market, By Type

  • 5.1 Introduction
  • 5.2 Bio-pharmacy
  • 5.3 Bio-industries
  • 5.4 Bio-services
  • 5.5 Bio-agriculture
  • 5.6 Bio-informatics
  • 5.7 Other Types

6 Global Biotechnology Market, By Product Type

  • 6.1 Introduction
  • 6.2 Instruments
  • 6.3 Reagents
  • 6.4 Software and Service
  • 6.5 Other Product Types

7 Global Biotechnology Market, By Technology

  • 7.1 Introduction
  • 7.2 Nanobiotechnology
  • 7.3 Tissue Engineering and Regeneration
  • 7.4 DNA Sequencing
  • 7.5 Cell-based Assays
  • 7.6 Fermentation
  • 7.7 Polymerase Chain Reaction (PCR) Technology
  • 7.8 Chromatography
  • 7.9 Other Technologies

8 Global Biotechnology Market, By Application

  • 8.1 Introduction
  • 8.2 Healthcare
  • 8.3 Food & Agriculture
  • 8.4 Natural Resources & Environment
  • 8.5 Industrial Processing
  • 8.6 Other Applications

9 Global Biotechnology Market, By End User

  • 9.1 Introduction
  • 9.2 Pharmaceutical and Biotechnology Companies
  • 9.3 Contract Research Organizations
  • 9.4 Academic and Research Institutes
  • 9.5 Other End Users

10 Global Biotechnology Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Siemens
  • 12.2 Novartis AG
  • 12.3 Amgen Inc.
  • 12.4 Johnson & Johnson Services, Inc.
  • 12.5 Merck KGaA
  • 12.6 General Electric
  • 12.7 Abbott Laboratories
  • 12.8 Novo Nordisk A/S
  • 12.9 Pfizer, Inc.
  • 12.10 Sanofi
  • 12.11 F. Hoffmann-La Roche Ltd.
  • 12.12 Vertex Pharmaceuticals Inc.
  • 12.13 Agilent Technologies Inc
  • 12.14 Olympus Corporation
  • 12.15 Sysmex Corporation
  • 12.16 Bristol-Myers Squibb
  • 12.17 Thermo Fisher Scientific
  • 12.18 AstraZeneca
  • 12.19 Danaher

List of Tables

  • Table 1 Global Biotechnology Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Biotechnology Market Outlook, By Type (2022-2030) ($MN)
  • Table 3 Global Biotechnology Market Outlook, By Bio-pharmacy (2022-2030) ($MN)
  • Table 4 Global Biotechnology Market Outlook, By Bio-industries (2022-2030) ($MN)
  • Table 5 Global Biotechnology Market Outlook, By Bio-services (2022-2030) ($MN)
  • Table 6 Global Biotechnology Market Outlook, By Bio-agriculture (2022-2030) ($MN)
  • Table 7 Global Biotechnology Market Outlook, By Bio-informatics (2022-2030) ($MN)
  • Table 8 Global Biotechnology Market Outlook, By Other Types (2022-2030) ($MN)
  • Table 9 Global Biotechnology Market Outlook, By Product Type (2022-2030) ($MN)
  • Table 10 Global Biotechnology Market Outlook, By Instruments (2022-2030) ($MN)
  • Table 11 Global Biotechnology Market Outlook, By Reagents (2022-2030) ($MN)
  • Table 12 Global Biotechnology Market Outlook, By Software and Service (2022-2030) ($MN)
  • Table 13 Global Biotechnology Market Outlook, By Other Product Types (2022-2030) ($MN)
  • Table 14 Global Biotechnology Market Outlook, By Technology (2022-2030) ($MN)
  • Table 15 Global Biotechnology Market Outlook, By Nanobiotechnology (2022-2030) ($MN)
  • Table 16 Global Biotechnology Market Outlook, By Tissue Engineering and Regeneration (2022-2030) ($MN)
  • Table 17 Global Biotechnology Market Outlook, By DNA Sequencing (2022-2030) ($MN)
  • Table 18 Global Biotechnology Market Outlook, By Cell-based Assays (2022-2030) ($MN)
  • Table 19 Global Biotechnology Market Outlook, By Fermentation (2022-2030) ($MN)
  • Table 20 Global Biotechnology Market Outlook, By Polymerase Chain Reaction (PCR) Technology (2022-2030) ($MN)
  • Table 21 Global Biotechnology Market Outlook, By Chromatography (2022-2030) ($MN)
  • Table 22 Global Biotechnology Market Outlook, By Other Technologies (2022-2030) ($MN)
  • Table 23 Global Biotechnology Market Outlook, By Application (2022-2030) ($MN)
  • Table 24 Global Biotechnology Market Outlook, By Healthcare (2022-2030) ($MN)
  • Table 25 Global Biotechnology Market Outlook, By Food & Agriculture (2022-2030) ($MN)
  • Table 26 Global Biotechnology Market Outlook, By Natural Resources & Environment (2022-2030) ($MN)
  • Table 27 Global Biotechnology Market Outlook, By Industrial Processing (2022-2030) ($MN)
  • Table 28 Global Biotechnology Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 29 Global Biotechnology Market Outlook, By End User (2022-2030) ($MN)
  • Table 30 Global Biotechnology Market Outlook, By Pharmaceutical and Biotechnology Companies (2022-2030) ($MN)
  • Table 31 Global Biotechnology Market Outlook, By Contract Research Organizations (2022-2030) ($MN)
  • Table 32 Global Biotechnology Market Outlook, By Academic and Research Institutes (2022-2030) ($MN)
  • Table 33 Global Biotechnology Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.